Marshall Wace North America’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $10.3M | Buy |
+511,674
| New | +$10.3M | 0.04% | 346 |
|
|
2021
Q1 | – | Sell |
-17,903
| Closed | -$394K | – | 1879 |
|
|
2020
Q4 | $394K | Sell |
17,903
-73,907
| -80% | -$1.63M | ﹤0.01% | 1128 |
|
|
2020
Q3 | $1.65M | Buy |
+91,810
| New | +$1.65M | 0.01% | 648 |
|
|
2020
Q2 | – | Sell |
-115,666
| Closed | -$2.13M | – | 1597 |
|
|
2020
Q1 | $2.13M | Sell |
115,666
-96,123
| -45% | -$1.77M | 0.02% | 468 |
|
|
2019
Q4 | $4.67M | Buy |
211,789
+211,274
| +41,024% | +$4.65M | 0.02% | 403 |
|
|
2019
Q3 | $8K | Buy |
+515
| New | +$8K | ﹤0.01% | 1268 |
|
|
2019
Q2 | – | Sell |
-17,886
| Closed | -$261K | – | 1786 |
|
|
2019
Q1 | $261K | Buy |
17,886
+12,939
| +262% | +$189K | ﹤0.01% | 923 |
|
|
2018
Q4 | $53K | Buy |
+4,947
| New | +$53K | ﹤0.01% | 1241 |
|